Inspire Medical Systems develops and commercializes the Inspire therapy system, an implantable hypoglossal nerve stimulator for moderate to severe obstructive sleep apnea. The device is activated during sleep and offers an alternative for patients who cannot tolerate CPAP. Physicians implant and manage the system; the company focuses on training, clinical support, and direct sales in sleep medicine.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 201.3 | — | 3 | — |
| Q2 2025 | 217.1 | — | -3.6 | -137.1% |
| Q3 2025 | 224.5 | — | 9.9 | -44.5% |
| Q4 2025 | 269.1 | — | 136.1 | 294.9% |
| Q1 2026 | 204.6 | 1.6% | -11.3 | -477.5% |
| Q2 2026 | 200.6 | -7.6% | 0.3 | — |
All markets — KeepWinning global stock screener
Other companies on NYSE: United Parks & Resorts Inc. (PRKS), DXC Technology Company (DXC), Nexa Resources S.A. (NEXA), Sonida Senior Living, Inc. (SNDA), Sixth Street Specialty Lending, Inc. (TSLX), SmartStop Self Storage REIT, Inc. (SMA)